ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$1.26
+0.03 (+2.44%)
Open$1.23
Previous Close$1.23
Day High$1.29
Day Low$1.21
52W High$85.80
52W Low$1.19
Volume—
Avg Volume262.1K
Market Cap4.39M
P/E Ratio—
EPS$-38.91
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,146.0% upside
Current
$1.26
$1.26
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 653.2K | 640.4K | 651.1K |
| Net Income | 176.4K | 175.3K | 172.4K |
| Profit Margin | 27.0% | 27.4% | 26.5% |
| EBITDA | 261.8K | 256.2K | 270.8K |
| Free Cash Flow | 66.8K | 83.8K | 75.0K |
| Rev Growth | -7.3% | -5.3% | +22.2% |
| Debt/Equity | 0.34 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |